Your browser doesn't support javascript.
loading
Role of Occult and Post-acute Phase Replication in Protective Immunity Induced with a Novel Live Attenuated SIV Vaccine.
Berry, Neil; Manoussaka, Maria; Ham, Claire; Ferguson, Deborah; Tudor, Hannah; Mattiuzzo, Giada; Klaver, Bep; Page, Mark; Stebbings, Richard; Das, Atze T; Berkhout, Ben; Almond, Neil; Cranage, Martin P.
Afiliação
  • Berry N; Division of Virology, National Institute for Biological Standards and Control, South Mimms, United Kingdom.
  • Manoussaka M; Institute for Infection & Immunity, St George's, University of London, London, United Kingdom.
  • Ham C; Division of Virology, National Institute for Biological Standards and Control, South Mimms, United Kingdom.
  • Ferguson D; Division of Virology, National Institute for Biological Standards and Control, South Mimms, United Kingdom.
  • Tudor H; Division of Virology, National Institute for Biological Standards and Control, South Mimms, United Kingdom.
  • Mattiuzzo G; Division of Virology, National Institute for Biological Standards and Control, South Mimms, United Kingdom.
  • Klaver B; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Page M; Division of Virology, National Institute for Biological Standards and Control, South Mimms, United Kingdom.
  • Stebbings R; Division of Biotherapeutics, National Institute for Biological Standards and Control, South Mimms, United Kingdom.
  • Das AT; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Almond N; Division of Virology, National Institute for Biological Standards and Control, South Mimms, United Kingdom.
  • Cranage MP; Institute for Infection & Immunity, St George's, University of London, London, United Kingdom.
PLoS Pathog ; 12(12): e1006083, 2016 Dec.
Article em En | MEDLINE | ID: mdl-28002473
ABSTRACT
In order to evaluate the role of persisting virus replication during occult phase immunisation in the live attenuated SIV vaccine model, a novel SIVmac239Δnef variant (SIVrtTA) genetically engineered to replicate in the presence of doxycycline was evaluated for its ability to protect against wild-type SIVmac239. Indian rhesus macaques were vaccinated either with SIVrtTA or with SIVmac239Δnef. Doxycycline was withdrawn from 4 of 8 SIVrtTA vaccinates before challenge with wild-type virus. Unvaccinated challenge controls exhibited ~107 peak plasma viral RNA copies/ml persisting beyond the acute phase. Six vaccinates, four SIVmac239Δnef and two SIVrtTA vaccinates exhibited complete protection, defined by lack of wild-type viraemia post-challenge and virus-specific PCR analysis of tissues recovered post-mortem, whereas six SIVrtTA vaccinates were protected from high levels of viraemia. Critically, the complete protection in two SIVrtTA vaccinates was associated with enhanced SIVrtTA replication in the immediate post-acute vaccination period but was independent of doxycycline status at the time of challenge. Mutations were identified in the LTR promoter region and rtTA gene that do not affect doxycycline-control but were associated with enhanced post-acute phase replication in protected vaccinates. High frequencies of total circulating CD8+T effector memory cells and a higher total frequency of SIV-specific CD8+ mono and polyfunctional T cells on the day of wild-type challenge were associated with complete protection but these parameters were not predictive of outcome when assessed 130 days after challenge. Moreover, challenge virus-specific Nef CD8+ polyfunctional T cell responses and antigen were detected in tissues post mortem in completely-protected macaques indicating post-challenge control of infection. Within the parameters of the study design, on-going occult-phase replication may not be absolutely required for protective immunity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Replicação Viral / Síndrome de Imunodeficiência Adquirida dos Símios / Vírus da Imunodeficiência Símia / Vacinas contra a SAIDS Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Replicação Viral / Síndrome de Imunodeficiência Adquirida dos Símios / Vírus da Imunodeficiência Símia / Vacinas contra a SAIDS Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido